Here are five observations:
1. A growing number of neurological disorder cases and increasing accessibility of technologically advanced neurosurgery equipment are boosting the market in North America and Europe.
2. An increase in research and development activities as well as awareness of brain diseases are also spurring the market in North America and Europe.
3. Asia will see growth in the market through 2021, due to more R&D activities and government funding. Additionally, more people are aware of neurological disorders and available treatments. China and Japan will lead the market growth in this region.
4. The costliness of neurosurgery equipment, strict regulatory requirements and unfavorable reimbursements are hindering the market’s growth.
5. A few key market trends include the growing popularity of neurostimulation devices for treating migraine, epilepsy, Parkinson’s disease and chronic pain, as well as a boost in mergers and acquisitions.
More articles on devices:
Corin Group to distribute FX Solution’s Reverse Shoulder System in U.S.
PEEK-OPTIMA™ HA Enhanced Devices — Drs. Timothy Bassett & Brad Prybis share early clinical experience
3 new spine, orthopedic device launches & releases — Feb. 23, 2017
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
